ELI LILLY & Co — Director's Dealing 2024

Feb 14, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-12

Reporting Person: White Anne E. (EVP & Pres, Lilly Neuroscience)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-12	Common Stock	A	5363	$737.26	Acquired	65569	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-12	Restricted Stock Unit	$	A	3269	Acquired	2025-02-01	Common Stock (3269)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.